HomeDabrafenibDabrafenib + Midazolam

Does Dabrafenib Interact with Midazolam?

Dabrafenib and Midazolam have a moderate drug interaction according to U.S. FDA drug labeling data. Dabrafenib decreased systemic exposure of midazolam (CYP3A4 substrate), potentially reducing efficacy. Monitor for loss of effectiveness. The mechanism involves cyp3a4 enzyme induction. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.

Severity
Moderate
Midazolam Class
Benzodiazepine
Management
Monitor for effects
Data Source
U.S. FDA via OpenFDA

How This Interaction Works

The interaction between Dabrafenib and Midazolam occurs because cyp3a4 enzyme induction. Clinically, this means dabrafenib decreased systemic exposure of midazolam (cyp3a4 substrate), potentially reducing efficacy. monitor for loss of effectiveness. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.

What To Tell Your Doctor or Pharmacist

If you are taking Dabrafenib and your doctor is considering prescribing Midazolam (or vice versa), make sure to:

  • Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
  • Ask whether the benefits of combining these medications outweigh the risks for your specific situation
  • Ask what symptoms to watch for that would indicate the interaction is causing problems
  • Ask whether any dosage adjustments are needed
  • Never stop or change either medication without first consulting your healthcare provider
💊 Dabrafenib(Tafinlar)+💊 Midazolam(Nayzilam)

Severity & Interaction Details

🟡
moderate
Be aware — moderate interaction
Documented interaction with manageable risk. May require dose adjustment or monitoring.
Severity scale
MinorContra
On record
Yes
Drug A class
Drug B class
Benzodiazepine
Source
NLP:dabrafenib

What this means in plain English

Dabrafenib decreased systemic exposure of midazolam (CYP3A4 substrate), potentially reducing efficacy. Monitor for loss of effectiveness.

About Dabrafenib and Midazolam

Midazolam is a Benzodiazepine. You may recognize them by the brand names Tafinlar and Nayzilam. Dabrafenib is taken by mouth, whereas Midazolam is given by intravenous (IV) infusion. Midazolam additionally carries an FDA boxed warning, the FDA's strongest safety alert.

What the FDA label says

"CYP3A4 enzyme induction"

📖 Source: NLP:dabrafenib

Share this result:

WhatsAppText / SMSEmail
Also share on:XFacebook
Add more drugs
Check Dabrafenib and Midazolam against your full medication list

Most patients take more than two medications. CDI checks every pair across up to 20 drugs simultaneously — including OTCs and common supplements.

Add more drugs →
Data integrity: Every interaction shown is extracted directly from official U.S. FDA drug labeling via openFDA and the U.S. National Library of Medicine (NIH) — no interactions are invented, inferred, or manually edited. Maintained by CheckDrugInteractions.com. See our methodology or report a correction at support@checkdruginteractions.com.

Data sourced from U.S. FDA drug labeling via openFDA and the NIH National Library of Medicine, supplemented with a small number of well-established interactions from curated clinical references. For informational purposes only. Always consult your pharmacist or physician.